Skip to Content

Gentaur Nivolumab – Anti-PD-1 Antibody

https://www.singlecell-congress.com/web/image/product.template/78939/image_1920?unique=6df2a9b
A research-grade biosimilar to nivolumab, targeting PD-1. Used in tumor immunology, TIL analysis, and immune modulation.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days